Researchers from Nobel Laureate David Baker’s lab at the University of Washington’s Institute for Protein Design have used AI to create antibodies from scratch, a major leap for drug discovery. Published in Nature, the breakthrough could transform the $200B antibody industry by replacing traditional, time-consuming methods with rapid, precise protein design for cancer and autoimmune therapies.
Nobel Winner’s Lab Notches Another Breakthrough: AI-Designed Antibodies that Hit their Targets
Share: